Work

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

Year: 2003

Type: article

Source: PubMed

Authors: Deepali Sachdev, Shu-Lian Li, Julie S Hartell, Yoko Fujita-Yamaguchi, Jeffrey S Miller, Douglas Yee

Institutions: University of Minnesota, Masonic Cancer Center, City Of Hope National Medical Center, City of Hope, Tokai University

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Targeting the IGF System in Breast Cancer

OpenAlex ID: W1583743328

FWCI: 10.07

Cites: 64

Cited by: 187

Related to: 10